Match each clinical presentation of a sexually transmitted infection to its most appropriate definitive antimicrobial management strategy based on current guidelines.
- Confirmed uncomplicated urogenital Neisseria gonorrhoeae (chlamydia negative) in a 75 kg patientCeftriaxone 500 mg intramuscularly as a single dose
- Primary syphilis presenting with a painless penile chancre in an immunocompetent adultBenzathine penicillin G 2.4 million units intramuscularly as a single dose
- Neurosyphilis presenting with tabes dorsalis and Argyll Robertson pupilsAqueous crystalline penicillin G 18-24 million units per day intravenously for 10-14 days
- Primary syphilis in a pregnant patient with a documented history of severe, IgE-mediated penicillin anaphylaxisInpatient penicillin desensitization followed by benzathine penicillin G therapy
Answer
Uncomplicated gonorrhea requires IM ceftriaxone; primary syphilis requires IM benzathine penicillin G; neurosyphilis requires IV aqueous crystalline penicillin G; and syphilis in a pregnant patient with a penicillin allergy requires desensitization prior to therapy.
Each sexually transmitted infection scenario dictates a highly specific regimen. Uncomplicated gonorrhea requires high-dose intramuscular ceftriaxone. Syphilis management hinges on the disease stage: primary syphilis needs single-dose intramuscular benzathine penicillin, whereas neurosyphilis demands continuous intravenous aqueous penicillin for adequate central nervous system penetration. In pregnancy, penicillin is the only agent proven to prevent congenital syphilis, making desensitization mandatory for allergic patients.
Step-by-Step Solution
Key Concept
Targeted antimicrobial therapy and desensitization protocols for specific sexually transmitted infections based on disease stage and patient demographics.